Abstract
The protein and peptide therapeutics have become an important class of drugs due to advancement in molecular biology and recombinant technology. There are more than 100 biopharmaceutical products approved and generating revenue of more than US $56 billion. A safe, effective and patient friendly delivery of these agents is the key to commercial success. Currently, most of therapeutic proteins are administered by the parenteral route which has many drawbacks. Various delivery strategies and specialized companies have evolved over the past few years to improve delivery of proteins and peptides. Polymeric depot and PEGylation technologies have overcome some of the issues associated with parenteral delivery. A considerable research has been focused on non-invasive routes such as pulmonary, per oral and transdermal for delivery of proteins and peptides, in order to increase patient compliance yet their delivery via non-invasive routes remains challenge due to their poor absorption and enzymatic instability. Pulmonary route has shown some success evidenced by recent FDA approval of inhalable insulin. Development of an oral dosage form for protein therapeutics is still the most desirable one but with greater challenge. This review presents the issues of delivery of proteins and peptides, current and potential formulation technologies to improve delivery and current market trends.
Keywords: PEGylation, Interferon alfa-2a, Eligard, Lipdization, Surgical implants, Small Molecule Carriers
Current Pharmaceutical Biotechnology
Title: Novel Delivery Technologies for Protein and Peptide Therapeutics
Volume: 7 Issue: 4
Author(s): T. R. Shantha Kumar, K. Soppimath and S. K. Nachaegari
Affiliation:
Keywords: PEGylation, Interferon alfa-2a, Eligard, Lipdization, Surgical implants, Small Molecule Carriers
Abstract: The protein and peptide therapeutics have become an important class of drugs due to advancement in molecular biology and recombinant technology. There are more than 100 biopharmaceutical products approved and generating revenue of more than US $56 billion. A safe, effective and patient friendly delivery of these agents is the key to commercial success. Currently, most of therapeutic proteins are administered by the parenteral route which has many drawbacks. Various delivery strategies and specialized companies have evolved over the past few years to improve delivery of proteins and peptides. Polymeric depot and PEGylation technologies have overcome some of the issues associated with parenteral delivery. A considerable research has been focused on non-invasive routes such as pulmonary, per oral and transdermal for delivery of proteins and peptides, in order to increase patient compliance yet their delivery via non-invasive routes remains challenge due to their poor absorption and enzymatic instability. Pulmonary route has shown some success evidenced by recent FDA approval of inhalable insulin. Development of an oral dosage form for protein therapeutics is still the most desirable one but with greater challenge. This review presents the issues of delivery of proteins and peptides, current and potential formulation technologies to improve delivery and current market trends.
Export Options
About this article
Cite this article as:
Shantha Kumar R. T., Soppimath K. and Nachaegari K. S., Novel Delivery Technologies for Protein and Peptide Therapeutics, Current Pharmaceutical Biotechnology 2006; 7 (4) . https://dx.doi.org/10.2174/138920106777950852
DOI https://dx.doi.org/10.2174/138920106777950852 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Identification of Functional Variants Associated with Obesity in Pakistani Kindred
Current Chinese Science Drug Resistance in Plasmodium: Natural Products in the Fight Against Malaria
Mini-Reviews in Medicinal Chemistry Nicotine Effects on Human Affective Functions: A Systematic Review of the Literature on a Controversial Issue
CNS & Neurological Disorders - Drug Targets Central G-Protein Coupled Receptors (GPCR)s as Molecular Targets for the Treatment of Obesity: Assets, Liabilities and Development Status
Current Drug Targets - CNS & Neurological Disorders Recent Patents and Developments in Glaucoma Biomarkers
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Nanomedicine against Alzheimer’s and Parkinson’s Disease
Current Pharmaceutical Design Latest Advances Towards the Discovery of 5-HT7 Receptor Ligands
Mini-Reviews in Medicinal Chemistry Inflammatory Signaling Networks as Targets for Pharmacological Intervention of Chronic Diseases
Current Signal Transduction Therapy Editorial (Thematic Issue: Metabolic Disorders, Drug Development, Drug Design and Biomarkers)
Current Pharmaceutical Design Pathophysiology of Myocardial Infarction and Acute Management Strategies
Cardiovascular & Hematological Agents in Medicinal Chemistry Common Genetic Variants of the Mitochondrial Trafficking System and Mitochondrial Uncoupling Proteins Affect the Development of Two Slowly Developing Demyelinating Disorders, Leukoaraiosis and Multiple Sclerosis
Current Medicinal Chemistry Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies
Mini-Reviews in Medicinal Chemistry Application of In Vivo Animal Models to Characterize the Pharmacokinetic and Pharmacodynamic Properties of Drug Candidates in Discovery Settings
Combinatorial Chemistry & High Throughput Screening A Comprehensive Review on Recent Developments in the Field of Biological Applications of Potent Pyrazolines Derived from Chalcone Precursors
Letters in Drug Design & Discovery Microfluidic Bioreactors for Highly Efficient Proteolysis
Current Chemical Biology Meet the Editorial Board Member
Current Pharmaceutical Biotechnology <i>In Vitro</i> Estimation of Photo-Protective Potential of Pomegranate Seed Oil and Development of a Nanoformulation
Current Nutrition & Food Science Meet Our Editorial Board Member
Pharmaceutical Nanotechnology Anticoagulant Activity of Sulfated Polysaccharides and Polyphenols Extracted from Marine Algae
Current Bioactive Compounds Searching for Potential Biomarkers of Penthorum chinense Pursh by Extraction Method and HPLC-MS Analysis Integrated with Evaluation of Hepatoprotective Effect
Current Pharmaceutical Analysis